Yukio Kageyama

4.5k total citations · 1 hit paper
152 papers, 3.5k citations indexed

About

Yukio Kageyama is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yukio Kageyama has authored 152 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Surgery, 44 papers in Pulmonary and Respiratory Medicine and 43 papers in Molecular Biology. Recurrent topics in Yukio Kageyama's work include Bladder and Urothelial Cancer Treatments (37 papers), Urinary and Genital Oncology Studies (20 papers) and Prostate Cancer Treatment and Research (19 papers). Yukio Kageyama is often cited by papers focused on Bladder and Urothelial Cancer Treatments (37 papers), Urinary and Genital Oncology Studies (20 papers) and Prostate Cancer Treatment and Research (19 papers). Yukio Kageyama collaborates with scholars based in Japan, United States and United Kingdom. Yukio Kageyama's co-authors include Kazunori Kihara, Satoru Kawakami, Yasuhisa Fujii, Sei Sasaki, Eric Huang, Minori Koshiji, Kenichi Ishibashi, J. Carl Barrett, Izumi Horikawa and Fumiaki Marumo and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Yukio Kageyama

148 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HIF‐1α induces cell cycle arrest by functionally counteracting Myc

2004 507 citations Yukio Kageyama, Eric Huang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yukio Kageyama Japan	30	1.6k	1.0k	999	817	757	152	3.5k
Hiroshi Kanetake Japan	34	2.0k 1.2×	959 0.9×	1.1k 1.1×	899 1.1×	796 1.1×	210	4.1k
Shuji Mikami Japan	36	1.7k 1.0×	1.3k 1.2×	1.5k 1.5×	955 1.2×	611 0.8×	206	4.1k
David Waltregny Belgium	38	2.3k 1.4×	1.3k 1.3×	932 0.9×	1.0k 1.2×	843 1.1×	98	5.1k
Mathilde Sibony France	33	2.0k 1.2×	1.4k 1.4×	1.4k 1.4×	735 0.9×	911 1.2×	128	4.4k
Lee Ann Baldridge United States	29	1.5k 0.9×	793 0.8×	616 0.6×	915 1.1×	332 0.4×	48	3.3k
Akiteru Goto Japan	35	1.9k 1.2×	568 0.5×	684 0.7×	973 1.2×	1.0k 1.4×	134	3.7k
Penelope Korkolopoulou Greece	40	1.9k 1.1×	762 0.7×	612 0.6×	1.2k 1.4×	779 1.0×	208	4.6k
Aria F. Olumi United States	34	1.9k 1.1×	747 0.7×	1.6k 1.6×	828 1.0×	969 1.3×	125	4.0k
W. Böcker Germany	38	1.8k 1.1×	918 0.9×	576 0.6×	1.3k 1.6×	890 1.2×	183	4.7k
Gerhard Seitz Germany	36	1.9k 1.2×	1.6k 1.5×	1.6k 1.6×	991 1.2×	518 0.7×	119	5.0k

Countries citing papers authored by Yukio Kageyama

Since Specialization

Citations

This map shows the geographic impact of Yukio Kageyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukio Kageyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukio Kageyama more than expected).

Fields of papers citing papers by Yukio Kageyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukio Kageyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukio Kageyama. The network helps show where Yukio Kageyama may publish in the future.

Co-authorship network of co-authors of Yukio Kageyama

This figure shows the co-authorship network connecting the top 25 collaborators of Yukio Kageyama. A scholar is included among the top collaborators of Yukio Kageyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukio Kageyama. Yukio Kageyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Inoue, Masaharu, Satoshi Washino, Suguru Shirotake, et al.. (2022). Clinical outcomes of nivolumab plus ipilimumab in patients with metastatic non‐clear cell renal cell carcinoma: Real‐world data from a Japanese multicenter retrospective study. International Journal of Urology. 30(9). 714–721. 9 indexed citations

Sekino, Yuta, Hitoshi Ishikawa, Tomokazu Kimura, et al.. (2021). Bladder preservation therapy in combination with atezolizumab and radiation therapy for invasive bladder cancer (BPT-ART) – A study protocol for an open-label, phase II, multicenter study. Contemporary Clinical Trials Communications. 21. 100724–100724. 6 indexed citations

Nakamura, Yuki, et al.. (2021). Screening of chronic radiation proctitis and colorectal cancer using periodic total colonoscopy after external beam radiation therapy for prostate cancer. Japanese Journal of Clinical Oncology. 51(8). 1298–1302. 4 indexed citations

Kageyama, Yukio, Yotsuo Higashi, Kazunori Kihara, et al.. (2013). Development of a novel interferon-α2b gene construct with a repetitive hypoxia-inducible factor binding site and its suppressive effects on human renal cell carcinoma cell lines in vitro. International Journal of Clinical Oncology. 19(3). 497–504. 2 indexed citations

Ishioka, Junichiro, Yukio Kageyama, Noboru Numao, et al.. (2010). RESULT OF TREATMENT FOR ADVANCED GERM CELL TUMOR IN THE LAST DECADE. The Japanese Journal of Urology. 101(3). 539–546. 1 indexed citations

Ishioka, Junichiro, Shuntaro Hara, John T. Isaacs, et al.. (2009). Suppression of mutant androgen receptors by flutamide. International Journal of Urology. 16(5). 516–521. 8 indexed citations

Ishioka, Junichiro, Yasuhisa Fujii, Yukio Kageyama, et al.. (2008). Cardiovascular events in survivors of high‐dose chemotherapy for germ cell tumors. International Journal of Urology. 15(7). 642–645. 6 indexed citations

Yoshida, Soichiro, Kazutaka Saito, Fumitaka Koga, et al.. (2008). C‐reactive protein level predicts prognosis in patients with muscle‐invasive bladder cancer treated with chemoradiotherapy. British Journal of Urology. 101(8). 978–981. 62 indexed citations

Ishioka, Junichiro, Yukio Kageyama, Yoshihiro Saito, et al.. (2007). BLADDER PRESERVATION BY CHEMORADIOTHERAPY IN COMBINATION WITH RADICAL TUR-BT IN MUSCLE INVASIVE BLADDER CANCER. The Japanese Journal of Urology. 98(6). 752–756. 1 indexed citations

10.

Kageyama, Yukio, Hiroshi Sugiyama, Hirohito Ayame, et al.. (2006). Suppression of VEGF transcription in renal cell carcinoma cells by pyrrole-imidazole hairpin polyamides targeting the hypoxia responsive element. Acta Oncologica. 45(3). 317–324. 27 indexed citations

11.

Ishibashi, Kenichi, Katsuki Kobayashi, Yukio Kageyama, & Sei Sasaki. (2006). Developmental expression and physiological roles of aquaporin‐11 in mice. The FASEB Journal. 20(5). 2 indexed citations

12.

Koga, Fumitaka, Yukio Kageyama, Satoru Kawakami, et al.. (2004). Prognostic Significance of Endothelial Per-Arnt-Sim Domain Protein 1/Hypoxia-Inducible Factor-2α Expression in a Subset of Tumor Associated Macrophages in Invasive Bladder Cancer. The Journal of Urology. 171(3). 1080–1084. 26 indexed citations

13.

Masuda, Hitoshi, et al.. (2004). Late relapse of stage I testicular seminoma metastatic to just a para‐ureteropelvic region. International Journal of Urology. 11(11). 1044–1046. 1 indexed citations

14.

Fujii, Yasuhisa, Satoru Kawakami, Yohei Okada, Yukio Kageyama, & Kazunori Kihara. (2004). Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells. American Journal of Physiology-Endocrinology and Metabolism. 286(6). E927–E931. 24 indexed citations

15.

Kageyama, Yukio, Yasuyuki Sakai, Gaku Arai, et al.. (2002). Intracavitary administration of OK‐432 with subcutaneous priming for malignant ascites in a case of advanced renal cell carcinoma. International Journal of Urology. 9(1). 57–59. 3 indexed citations

16.

Kageyama, Yukio, et al.. (2000). Intrathoracic herniation of the kidney. Urology. 55(1). 143–144. 6 indexed citations

17.

Fujii, Yasuhisa, Masayuki Yoshida, Kazunori Kihara, et al.. (2000). Significance of Carbohydrate Antigen Sialyl-Lewis X, Sialyl-Lewis A, and Possible Unknown Ligands to Adhesion of Human Urothelial Cancer Cells to Activated Endothelium. Urologia Internationalis. 64(3). 129–133. 14 indexed citations

18.

Yoshimura, Ryoichi, Hozumi Fukuda, Akihiko Hoshi, et al.. (1999). Reduction of acute and late complications by the treatment with 3-D conformation radiotherapy for prostate cancer. A comparison with other techniques. 44(4). 477–483. 2 indexed citations

19.

Fujii, Yasuhisa, Yukio Kageyama, Satoru Kawakami, Kazunori Kihara, & Hiroyuki Oshima. (1999). Detection of Disseminated Urothelial Cancer Cells in Peripheral Venous Blood by a Cytokeratin 20‐specific Nested Reverse Transcriptase‐Polymerase Chain Reaction. Japanese Journal of Cancer Research. 90(7). 753–757. 29 indexed citations

20.

Kageyama, Yukio, et al.. (1989). A STUDY OF INTERCELLULAR COMMUNICATION OF HUMAN TRANSITIONAL CELL CARCINOMA CELL LINES. The Japanese Journal of Urology. 80(7). 988–994. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact